Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1585426 | 1.00 | LTA4H (0.48) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL2700090 | 1.00 | LTA4H (0.48) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL25923107 | 1.00 | LTA4H (0.48) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL1246190 | 0.98 | MAPT (0.50) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL1964301 | 0.98 | MAPT (0.50) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL2549430 | 0.98 | MAPT (0.50) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL2542574 | 0.94 | BLM (0.50) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL17583510 | 0.85 | ACE2 (0.44) | LTA4HBLMCYP1A2MAPTCYP2D6 | |
| SCHEMBL2549304 | 0.85 | — | — | |
| Ornithine Aketoglutarate SCHEMBL2323479 | 0.83 | GSR (0.53) | LTA4HBLMCYP1A2MAPTCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565474-B2 | Discovery, total synthesis, and bioactivity of doscadenamides | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-03-03 | — | — | US | disclosed |
| US-20250270567-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS INC (US) | 2025-08-28 | — | — | US | disclosed |
| US-12123004-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2024-10-22 | — | — | US | disclosed |
| US-12031167-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-20230242482-A9 | DISCOVERY, TOTAL SYNTHESIS, AND BIOACTIVITY OF DOSCADENAMIDES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-08-03 | — | — | US | disclosed |
| US-20220281816-A1 | DISCOVERY, TOTAL SYNTHESIS, AND BIOACTIVITY OF DOSCADENAMIDES | University of Florida Research Foundation, Incorporation (US) | 2022-09-08 | — | — | US | disclosed |
| US-20220259626-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS, INC. | 2022-08-18 | — | — | US | disclosed |
| US-11155843-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2021-10-26 | — | — | US | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| US-20210062234-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS, INC. | 2021-03-04 | — | — | US | disclosed |
| US-20180340198-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS, INC. | 2018-11-29 | — | — | US | disclosed |
| US-9970036-B2 | Generation of acyl amino acids | MODULAR GENETICS, INC. (US) | 2018-05-15 | — | — | US | disclosed |
| US-20160206680-A1 | ANTI-TRYPANOSOME COMPOUNDS AND TREATMENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-07-21 | — | — | US | disclosed |
| US-9321811-B2 | Further novel anti-parasitic compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-04-26 | — | — | US | disclosed |
| US-20160076065-A1 | GENERATION OF ACYL AMINO ACIDS | MODULAR GENETICS, INC. | 2016-03-17 | — | — | US | disclosed |
| US-20140221276-A1 | FURTHER NOVEL ANTI-PARASITIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-08-07 | — | — | US | disclosed |
| US-8772247-B2 | Anti-parasitic compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-07-08 | — | — | US | disclosed |
| US-20120108502-A1 | NOVEL ANTI-PARASITIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY TRANSFER (US) | 2012-05-03 | — | — | US | disclosed |
| US-20110263815-A1 | TRIAZOLE MACROCYCLE SYSTEMS | AILERON THERAPEUTICS, INC., A DELAWARE CORPORATION (US) | 2011-10-27 | — | — | US | disclosed |
| WO-2010108164-A2 | NOVEL ANTI-PARASITIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281816-A1 | DISCOVERY, TOTAL SYNTHESIS, AND BIOACTIVITY OF DOSCADENAMIDES | PDE9A, CGAS, PDE8A | LTA4H 1150/4885BLM 1842/4885CYP1A2 2255/4885 |
| US-20110263815-A1 | TRIAZOLE MACROCYCLE SYSTEMS | FLT3, VIP, NGLY1 | LTA4H 3788/4885BLM 2527/4885CYP1A2 3488/4885 |
| US-20220259626-A1 | GENERATION OF ACYL AMINO ACIDS | FADS1, FADS2, FAR1 | LTA4H 635/4885BLM 4842/4885CYP1A2 2540/4885 |
| US-20120108502-A1 | NOVEL ANTI-PARASITIC COMPOUNDS | NGLY1, PTMS, LRBA | LTA4H 35/4885BLM 3585/4885CYP1A2 4265/4885 |
| US-20180340198-A1 | GENERATION OF ACYL AMINO ACIDS | FADS1, FADS2, COASY | LTA4H 700/4885BLM 4814/4885CYP1A2 2715/4885 |
| US-12031167-B2 | Generation of acyl amino acids | FADS1, FADS2, FAR1 | LTA4H 635/4885BLM 4842/4885CYP1A2 2540/4885 |
| US-12565474-B2 | Discovery, total synthesis, and bioactivity of doscadenamides | TRPC6, NPR1, ADCY6 | LTA4H 1597/4885BLM 3568/4885CYP1A2 4264/4885 |
| US-20210062234-A1 | GENERATION OF ACYL AMINO ACIDS | FADS1, FADS2, COASY | LTA4H 700/4885BLM 4814/4885CYP1A2 2715/4885 |
| US-20230242482-A9 | DISCOVERY, TOTAL SYNTHESIS, AND BIOACTIVITY OF DOSCADENAMIDES | PDE9A, CGAS, PDE8A | LTA4H 1150/4885BLM 1842/4885CYP1A2 2255/4885 |
| US-20160206680-A1 | ANTI-TRYPANOSOME COMPOUNDS AND TREATMENTS | PDF, TUFM, TRAP1 | LTA4H 179/4885BLM 2198/4885CYP1A2 4748/4885 |
| US-20140221276-A1 | FURTHER NOVEL ANTI-PARASITIC COMPOUNDS | PTMS, LRBA, PDF | LTA4H 25/4885BLM 3369/4885CYP1A2 4317/4885 |
| US-11155843-B2 | Generation of acyl amino acids | FADS1, FADS2, COASY | LTA4H 700/4885BLM 4814/4885CYP1A2 2715/4885 |
| US-20160076065-A1 | GENERATION OF ACYL AMINO ACIDS | ASNS, DNPEP, BCAT1 | LTA4H 1665/4885BLM 4635/4885CYP1A2 4296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.